Involvement of apoptosis in patients with diabetic nephropathy: A study on plasma soluble Fas levels and pathological findings

Nephrology

Volumn 9, Issue 2, 2004, Pages 94-99

  Baba, Kaori ^a   Minatoguchi, Shinya ^a   Sano, Hirotake ^a   Kagawa, Tomoyo ^a   Murata, Ichijiro ^a   Takemura, Genzou ^a   Hirano, Takahiro ^a   Ohashi, Hiroshige ^b   Takemura, Masao ^a   Fujiwara, Takako ^c   Fujiwara, Hisayoshi ^a  

^a GIFU UNIVERSITY   (Japan)

^b GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

^c KYOTO WOMEN'S UNIVERSITY   (Japan)

Author keywords

Apoptosis; Diabetic nephropathy; Soluble Fas; Urinary albumin

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; CYCLINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FAS ANTIGEN; NUCLEAR PROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NICK END LABELING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN URINE LEVEL; URINE LEVEL;

ALBUMINURIA; ANTIGENS, CD95; APOPTOSIS; CREATININE; DIABETIC NEPHROPATHIES; HUMANS;

EID: 11144356200     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2004.00238.x     Document Type: Article

References (16)

1. Kelly DJ, Cox AJ, Tolcos M, Cooper ME, Wilkinson-Berka JL, Gilbert RE. Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats. Kidney Int. 2002; 61: 31-9.
2. Sano H, Asano K, Minatoguchi S et al. Plasma soluble Fas and soluble Fas ligand in chronic glomerulonephritis. Nephron 1998; 80: 153-61.
3. Makino H, Sugiyama H, Kashihara N. Apoptosis and extracellular matrix-cell interactions in kidney disease. Kidney Int. 2000; 77 (Suppl.): S67-75.
4. Wolf G. Cell cycle regulation in diabetic nepropathy. Kidney Int. 2000; 77 (Suppl.): S59-66.
5. Seishima M, Takemura M, Saito K et al. Highly sensitive ELISA for soluble Fas in serum: Increased soluble Fas in the elderly. Clin. Chem. 1996; 42: 1911-14.
6. World Health Organisation. Biomedical Research. WHO Chronicle 1976; 30: 390-62.
7. Cheng J, Zhou T, Liu C et al. Protection from Fas-mediated apoptosis by a soluble from of the Fas molecule. Science 1994; 263: 1759-62.
8. Inoue CN. LPA as a determinant of mesangial growth and apoptosis. Semin. Nephrol. 2002; 22: 415-22.
9. Verzola D, Bertolotto MB, Villaggio B et al. Taurine prevents apoptosis-induced high ambient glucose human tubule renal cells. J. Investig. Med. 2002; 50: 443-51.
10. Watanabe-Fukunaga R, Brannan CI, Itoh N et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 1992; 148: 1274-9.
11. Nishigaki K, Minatoguchi S, Seishima M et al. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure. J. Am. Coll. Cardiol. 1997; 29: 1214-20.
12. Perianayagam MP, Murray SL, Balakrishnan VS et al. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure. J. Lab. Clin. Med. 2000; 136: 320-7.
13. Houlihan CA, Tsalamandris C, Akdeniz A, Jerums C. Albumin to creatinine ratio: A screening test with limitations. Am. J. Kidney Dis. 2002; 39: 1183-9.
14. Tabaei BP, Al-Kassab AS, Ilag LL, Zawacki CM, Herman WH. Does microalbuminuria predict diabetic nephropathy? Diabetes Care 2001; 24: 1560-6.
15. Dahlquist G, Stattin EL, Rudberg S. Urinary albumin excretion rate and glomerular filtration rate in the prediction of diabetic nephropathy; a long- term follow-up study of childhood onset type-1 diabetic patients. Nephrol. Dial. Transplant. 2001; 16: 1382-6.
16. Caramori ML, Floretto P, Mauer M. The need for early predictors of diabetic nephropathy risk: Is albumin excretion rate sufficient? Diabetes 2000; 49: 1399-408.